ADM Tronics Unlimited, Inc. (OTCQB: ADMT) has announced that a Premarket Notification 510(k) application has been filed with the US Food and Drug Administration ("FDA") for Angiodroid The CO 2 ...
ANGIODROID Srl, an Italian manufacturer of medical technologies, announces the CE mark for ANGIOPULSE, its first intra-aortic balloon pump (IABP) device. The new ANGIOPULSE IABP incorporates a new ...
ADM Tronics Unlimited, Inc. (OTCQB: ADMT) has announced that Angiodroid America, Inc. has withdrawn its Premarket Notification 510(k) application filed with the US Food and Drug Administration ("FDA") ...
Angiodroid today announced the successful close of its €7 million Series A financing round to strengthen international expansion through commercial partnerships and investments in salesforce, in order ...
Angiodroid, Srl is a privately owned Italian entity. Angiodroid America, Inc., founded last year in affiliation with Triotech Ventures and ADMT, is a majority-owned subsidiary of Angiodroid, Srl. ADMT ...